Bayer, the global enterprise with core competencies in the Life Science fields of health care and agriculture, announces their plans to bring 500 jobs to Creve Coeur.
The investment was made to try to help enhance Missouri’s already successful and growing agriculture-technology industry.
The 500 St. Louis jobs would be a combination of transfers from North Carolina and new hires.
JEFFERSON CITY Bayer AG plans to bring 500 jobs to Creve Coeur, Gov. Mike Parson said from his office on Tuesday.
The announcement comes nearly three years after Bayer announced its $63 billion acquisition of Creve Coeur-based Monsanto Co., which generated worry that the merger would result in local job losses. The combined companys seeds and traits business and its North American commercial headquarters is based in St. Louis.
Parson, a Republican, said Bayer has committed to retaining 4,400 jobs in the St. Louis region as well as adding 500 more; the average salary for the new jobs will be $110,000, state officials said.
“This investment will just enhance Missouri’s already successful ag-tech industry,” said Parson, a cattle farmer. He met with Bayer CEO Werner Baumann during a European trade mission last month.
The announcement was made possible in part by the shuttering of Bayer’s North American crop sciences headquarters in Raleigh, N.C., said Lisa Safarian, president of Bayer’s North America commercial operations.
She said the 500 St. Louis jobs would be a combination of transfers from North Carolina and new hires.
“Bayer’s headquarters was in Raleigh, North Carolina,” Safarian said at a Tuesday news conference. “And so that headquarters is closing, and so we will be locating those individuals to St. Louis.”
A company spokesman later said Bayer’s environmental science operations will remain in Cary, N.C.
The St. Louis job announcement also comes after the company, whose international headquarters is based in Germany, announced in November it would cut 12,000 jobs worldwide, about 10% of its workforce. The company also faces continued litigation, inherited from Monsanto, regarding its signature weedkiller Roundup, which plaintiffs claim caused their cancers.
It wasn’t clear whether the 4,900 jobs 4,400 retained jobs and 500 new ones represented a net gain for staffing levels in St. Louis.
Bayer had been in discussions with state economic development officials as it weighed investing in its workforce here or on the east coast. The company told the Post-Dispatch in 2018 that it employed about 5,400 people between its two St. Louis area campuses.
In September 2016, after the two companies announced the merger, Monsanto said it employed 4,100 people in the St. Louis region, not including several hundred remote workers, temporary employees or contractors.
The state and Bayer also announced Tuesday the company would make a $164 million capital investment as part of the deal mostly building improvements to accommodate the new staff, a company spokesman said.
The state has offered incentives totaling $44 million, mainly through its Missouri Works program that allows companies to retain employees’ payroll taxes if job targets are met. The state incentives would be paid over seven years. St. Louis County is also offering a property tax break valued at $2 million.
Rob Dixon, director of the state’s Department of Economic Development, framed Bayer’s decision as a win for Missouri.
“We look at this, again, as making a strategic investment in the state,” Dixon said. “The state was competing for these jobs. … We’re competing for the long-term economic opportunity for our state.”
St. Louis County Executive Sam Page cheered the news at the press conference.
“As St. Louis County continues to shine as the global epicenter for agricultural technology, and plant sciences, I thank Bayer for adding to our momentum,” Page, a Democrat, said.
Bayer’s predecessor, Monsanto, received a significant pledge of state support in 2013 when it announced a $400 million investment into its Chesterfield research campus. The state promised up to $22 million in incentives, and St. Louis County $22 million in tax breaks, in exchange for the company adding 675 scientific jobs in Chesterfield.
Bayer began integrating Monsanto into its corporate structure last August.
In January, Bayer announced it would shutter its Pittsburgh campus, for decades the German conglomerates North American headquarters, and consolidate administrative staff for plant sciences in St. Louis and for health care in New Jersey.
Its Pittsburgh operations, which employed about 600 people in finance, accounting, legal and technology, will shutter by 2021, according to the Pittsburgh Post-Gazette.
Bayer is looking at adding jobs to the Creve Coeur campus, where Monsantos headquarters staff, as opposed to its Chesterfield-based scientific and research staff, is based.
A company spokesman said Tuesday the job classifications would “run the gamut,” and would include positions in information technology, marketing, legal, human resources and research and development.
Some of the jobs could end up being based at the company’s Chesterfield campus, said Darren Wallis, a Bayer spokesman.
Headquarters jobs, which include business support functions, are often the most at risk following major corporate mergers. Overlapping information technology and human resources departments, for instance, can often be consolidated. The investment in the Creve Coeur campus, the former global headquarters for Monsanto, helps alleviate at least some worry about major cutbacks in corporate jobs there following the merger.
Jacob Barker of the Post-Dispatch contributed to this report.